Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Day One Biopharmaceuticals, Inc. (DAWN)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 87,040,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Day One Biopharmaceuticals is a clinical-stage biopharmaceutical company. Co. is engaged in developing and commercializing targeted therapies for patients with genomically-defined cancers. Co.'s main product candidate, DAY101 (tovorafenib), is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, kinase inhibitor. Co.'s second product candidate, pimasertib, is an oral, highly-selective small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2 (MEK), a well-characterized key signaling node in the RAS/mitogen-activated protein kinase pathway.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 2,244,684 4,978,018
Total Buy Value $0 $0 $24,978,318 $65,978,328
Total People Bought 0 0 1 3
Total Buy Transactions 0 0 4 7
Total Shares Sold 85,781 95,866 106,432 4,385,657
Total Sell Value $1,340,327 $1,458,221 $1,603,792 $59,625,737
Total People Sold 4 4 4 8
Total Sell Transactions 8 12 19 97
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 168
  Page 1 of 7  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Blackman Samuel C. HEAD OF R&D   •       –      –    2024-04-18 4 AS $16.02 $160,163 D/D (10,000) 1,174,662     -
   Blackman Samuel C. HEAD OF R&D   •       –      –    2024-03-25 4 AS $16.01 $160,055 D/D (10,000) 1,184,662     -
   Blackman Samuel C. HEAD OF R&D   •       –      –    2024-03-11 4 AS $15.24 $457,314 D/D (30,000) 1,194,662     -
   Blackman Samuel C. HEAD OF R&D   •       –      –    2024-02-27 4 AS $16.11 $322,166 D/D (20,000) 1,224,662     -
   York Charles N Ii COO, CFO AND SECRETARY   •       –      –    2024-02-16 4 S $15.25 $40,651 D/D (2,666) 277,754     -
   Dubow Adam GENERAL COUNSEL   •       –      –    2024-02-16 4 S $15.25 $49,434 D/D (3,242) 16,585     -
   Blackman Samuel C. HEAD OF RESEARCH AND DEVELOPME   •       –      –    2024-02-16 4 S $15.25 $34,430 D/D (2,258) 1,244,662     -
   Bender Jeremy CHIEF EXECUTIVE OFFICER   •       •      –    2024-02-16 4 S $15.25 $116,114 D/D (7,615) 721,813     -
   York Charles N Ii COO, CFO AND SECRETARY   •       –      –    2024-02-15 4 OE $0.00 $0 D/D 10,250 280,420     -
   Dubow Adam GENERAL COUNSEL   •       –      –    2024-02-15 4 OE $0.00 $0 D/D 8,399 19,827     -
   Blackman Samuel C. HEAD OF RESEARCH AND DEVELOPME   •       –      –    2024-02-15 4 OE $0.00 $0 D/D 8,686 1,246,920     -
   Bender Jeremy CHIEF EXECUTIVE OFFICER   •       •      –    2024-02-15 4 OE $0.00 $0 D/D 19,999 729,428     -
   Dubow Adam General Counsel   •       –      –    2023-11-16 4 S $11.69 $62,109 D/D (5,313) 11,428     -
   York Charles N Ii COO, CFO and Secretary   •       –      –    2023-11-16 4 S $11.69 $11,176 D/D (956) 270,170     -
   Bender Jeremy Chief Executive Officer   •       •      –    2023-11-16 4 S $11.69 $36,321 D/D (3,107) 709,429     -
   Blackman Samuel C. Head of Research and Developme   •       –      –    2023-11-16 4 S $11.69 $8,288 D/D (709) 1,238,234     -
   Dubow Adam General Counsel   •       –      –    2023-11-15 4 OE $0.00 $0 D/D 13,600 16,741     -
   York Charles N Ii COO, CFO and Secretary   •       –      –    2023-11-15 4 OE $0.00 $0 D/D 3,625 271,126     -
   Bender Jeremy Chief Executive Officer   •       •      –    2023-11-15 4 OE $0.00 $0 D/D 8,312 712,536     -
   Blackman Samuel C. Head of Research and Developme   •       –      –    2023-11-15 4 OE $0.00 $0 D/D 2,624 1,238,943     -
   Dubow Adam General CounselOfficer   •       –      –    2023-11-06 3 IO $0.00 $0 D/D 0 3,141     -
   Blavatnik Len Affiliate of 10% Owner   –       –      –    2023-10-20 4 B $9.97 $1,110,907 D/D 111,387 12,929,322 2.44     -
   Blavatnik Len Affiliate of 10% Owner   –       –      –    2023-10-19 4 B $10.06 $3,867,372 D/D 384,400 12,817,935 2.44     -
   Blavatnik Len Affiliate of 10% Owner   –       –      –    2023-10-18 4 B $10.21 $10,000,049 D/D 979,667 12,433,535 2.44     -
   Bender Jeremy Chief Executive Officer   •       •      –    2023-08-17 4 S $13.86 $41,525 D/D (2,996) 704,224     -
  168 Records found
  1  2  3  4  5  6  7   
  Page 1 of 7
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us